COVID-19 Retrospective Study of Chest CTs from China: What is the Re…

Adam Bernheim

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

Michael Gallagher

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

Fellows’ Case Files: University of Pittsburgh

PulmPEEPs

D. Furfaro, K. Montemayor, S. Maximous, R. Wojcik

Molecular Testing on EBUS-TBNA Specimen

Cleveland Clinic Respiratory Institute

A. C. Mehta

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Central Airway Obstruction

Houston Methodist

T. Dammad

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Approach to Adenopathy and Lung Nodules: A Case Based Discussion

Cleveland Clinic Respiratory Institute

S. Goel, G. Senyei

Hot Topics in Heart Failure ACC.22

ACC 2022 Conference Coverage

N. Ibrahim

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

MUSC Cardiology

S. Litwin

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

First-in-man Use of Electrosurgical SESAME (SEptal Scoring Along the…

University of Miami

C. Sanina

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch